Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Notice of Ex-Dividend Reference Price (Hyundai Motor Preferred) / 2024-02-27 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Submission of Audit Report / 2024-02-28 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Submission of Audit Report / 2026-02-12 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Change of Market Division / 2025-04-30 Disclosures
  • [Disclosure] Celltrion (068270) – Clarification of Rumors or Reports (Unconfirmed) / 2025-08-27 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Decision on General Shareholders Meeting / 2026-02-19 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-04-20 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Setting of Record Date or Period for Suspension of Shareholder Register / 2024-08-01 Disclosures

[Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21

Posted on January 21, 2026August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion has decided to dispose of 11,379 common treasury shares (approx. KRW 1.65B) to grant shares following the exercise of stock options by 10 employees.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Decision on Disposal of Treasury Shares
  • Number of Shares to be Disposed: 11,379 common shares
  • Disposal Price per Share: KRW 144,840 (Weighted average exercise price based on exercised share volume)
  • Estimated Total Disposal Amount: KRW 1,648,139,691 (approx. KRW 1.65B)
  • Scheduled Disposal Period: January 21, 2026 (Start and end date identical)
  • Purpose of Disposal: Delivery of treasury shares following stock option exercises
  • Method of Disposal: Other (Direct transfer to individual employee brokerage accounts)
  • Counterparties: 10 company executives and employees
  • Treasury Share Holdings Prior to Disposal:
    • Acquired within dividend availability: 7,165,466 common shares (3.1%)
    • Other acquisitions: 5,182,379 common shares (2.2%)
    • Total Treasury Shares: 12,347,845 common shares
  • Board / Internal Approval Date: January 21, 2026 (Date of internal approval document)
  • Expected Dilution Effect: Disposed treasury shares represent 0.00% of total issued shares, resulting in negligible equity dilution.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Treasury Share Delivery Completion and Shareholding Changes

This disclosure details Celltrion’s decision to dispose of 11,379 common treasury shares to satisfy stock option exercises by 10 employees, making it important to confirm the completion of share transfers according to the scheduled timeline. Tracking the transfer ensures verification of changes in remaining treasury share balances and ownership ratios. Updated treasury share status can be verified under ‘Acquisition and Disposal Status of Treasury Shares’ in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21
Next Post: [Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Presentation / 2026-01-21

Related Posts

  • [Disclosure] PSK Holdings (031980) – Submission of Audit Report / 2026-03-20 Semiconductors
  • [Disclosure] SK Square (402340) – Decision on Paid-in Capital Increase / 2026-06-24 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Shares and Equity Securities of Other Corporation (Voluntary Disclosure) / 2025-03-06 Semiconductors
  • [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release / 2025-07-18 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Provisional Operating Results (Consolidated) / 2025-07-25 Semiconductors
  • [Disclosure] Hana Micron (067310) – Subscription Results of Capital Increase or Equity-Linked Bonds (Voluntary Disclosure) / 2024-07-31 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Submission of Audit Report / 2026-03-13 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Closure of Shareholder Register / 2025-07-14 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Acquisition of Shares or Equity Securities of Other Corporations / 2025-01-08 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2025-08-27 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Loan to Others / 2024-09-11 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Rights Issue (Major Management Matters of Subsidiary) / 2025-09-01 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision to Call General Shareholders’ Meeting / 2025-02-19 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme